Related Experiment Videos
Antibiotic resistance in Haemophilus influenzae: epidemiology, mechanisms, and therapeutic possibilities
Abstract:
The prevalence of antibiotic resistance in Haemophilus influenzae is increasing. The encapsulated strains of group b are the strains that are most important in the pathogenesis of severe systemic infections, and it is in this group that the incidence of resistance is highest. Strains simultaneously resistant to ampicillin, chloramphenicol, and tetracycline are rare but have been isolated in several parts of the world. Transferable antibiotic resistance is well documented, and both small (3.6 megadaltons) and large (38-42 megadaltons) plasmids mediating beta-lactamase and chloramphenicol acetyltransferase production and tetracycline resistance have been detected in H. influenzae. The possibilities for treatment of infections due to such organisms include the use of the newer cephalosporins, of a combination of a beta-lactamase inhibitor and ampicillin, and of alternate agents such as minocycline and trimethoprim. Sporadic strains resistant to these agents have also been reported.
Insights
Antibiotic resistance in Haemophilus influenzae, particularly in group b strains, is rising. Rare strains resistant to multiple antibiotics like ampicillin, chloramphenicol, and tetracycline have emerged globally.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Increasing prevalence of antibiotic resistance in Haemophilus influenzae.
- Encapsulated group b strains are key in severe infections and show highest resistance.
- Simultaneous resistance to ampicillin, chloramphenicol, and tetracycline is rare but documented globally.
Purpose of the Study:
- To review the current status of antibiotic resistance in Haemophilus influenzae.
- To highlight the significance of transferable resistance mechanisms.
- To discuss treatment options for infections caused by resistant strains.
Main Methods:
- Literature review of studies on Haemophilus influenzae antibiotic resistance.
- Analysis of documented cases of multi-drug resistant strains.
- Examination of plasmid-mediated resistance mechanisms.
Main Results:
- Haemophilus influenzae exhibits increasing antibiotic resistance, especially encapsulated group b strains.
- Rare strains resistant to ampicillin, chloramphenicol, and tetracycline have been identified worldwide.
- Transferable resistance via plasmids (3.6 Mdal and 38-42 Mdal) encoding beta-lactamase, chloramphenicol acetyltransferase, and tetracycline resistance has been detected.
Conclusions:
- Emergence of multi-drug resistant Haemophilus influenzae poses a significant clinical challenge.
- Treatment options include newer cephalosporins, ampicillin with beta-lactamase inhibitors, and alternative agents like minocycline and trimethoprim.
- Continued surveillance and development of new therapeutic strategies are crucial.